As the global medical device market surges—projected to expand from $678.88 billion in 2025 to more than $1.1 trillion by 2034—Nigeria’s Platos Health is emerging as a promising local player in a space long dominated by global giants like Omron.
While most African healthtech startups focus on telemedicine, Platos Health is charting a different course by developing smart, AI-powered devices for home-based health monitoring. The Lagos-based startup recently closed a $1.4 million pre-seed funding round to scale its operations and expand its reach.
The round was led by Google for Startups and Invest International, with participation from angel investors affiliated with Google, Tesla, and Unicredit.
Founded in 2020 by Joseph Fakayode, Platos Health has developed the Platos Body Monitor, a clinically validated device capable of tracking 49 different health indicators, including body weight, heart rate, BMI, hydration, body fat, and visceral fat. The device syncs seamlessly with the Platos Monitor software, which is available across Android, iOS, and web platforms.
Additionally, the platform integrates with both Apple Health and Google Health Connect, allowing users to build a centralised, comprehensive view of their health data. An embedded AI engine offers personalised health recommendations based on the data collected.
Platos Health is stepping into a critical gap in Nigeria’s healthcare landscape. With under 500 cardiologists serving a population of over 200 million and chronic diseases on the rise, the company aims to offer affordable, preventative health solutions outside of the traditional hospital environment.
The startup estimates a $30 million addressable market within Nigeria. Its devices, priced between ₦80,000 ($50) and ₦120,000 ($80), are already available in leading pharmacy chains such as Medplus and Justrite.
By focusing on in-home health tracking and AI-driven insights, Platos Health joins the ranks of healthtech pioneers like MDaaS and WellaHealth that are reimagining access to care in Nigeria. This fresh capital injection is expected to bolster Platos Health’s ability to scale and potentially spark greater African participation in the global medical device market—an industry where local voices have long been underrepresented.